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One of the problems associated with jet ventilation is the difficulty in controlling expiration. Outflow of gas has to take place passively through the upper airway. In a CICV situation, one can never be sure whether an obstructed upper airway will open up or will stay blocked after initiation of highpressure jet ventilation. Obstruction of the outflow tract, insufficient expiratory time, or both can result in air trapping with subsequent barotrauma and haemodynamic instability. 2 -4 Oedema, laryngospasm, and the presence of surgical instruments have all been reported to compromise the outflow of gas. 3 5 6 Time needed for passive backflow of gas depends on the resistance of the outflow tract (determined by its diameter and length) and on the driving force (determined by the compliance of the respiratory system which results from the elasticity of the lungs and the chest wall). If the diameter of the natural or artificial airway is restricted below a critical point (4 mm usually being considered as the cut-off point), exhalation time is prolonged exponentially. 7 Air trapping becomes a real danger if the expiratory time in relation to the diameter and length of the outflow tract is too short. 8 9 Changing the I:E ratio only provides a partial solution to the problem. A bidirectional ventilatory system that requires only a small-bore airway catheter for both the delivery of oxygen to the lungs and the outflow of gas could completely solve the above-mentioned problems associated with jet ventilation. Application of jet flow generated suction has been proposed to facilitate expiration through largebore small-bore catheters have not found their way into clinical practice. 12 -14 Recently, we described a modified industrial ejector (SBP 07) using expiratory ventilation assistance (EVA) based on the Bernoulli principle. 15 Although a minute volume of up to 6 litre min 21 could be achieved through a 75 mm long, 2 mm ID transtracheal catheter, this industrial ejector is not specified for ventilation but has been designed to create a maximum negative pressure to pick up and hold parts during industrial manufacturing processes. Therefore, we developed and tested in several bench studies a novel ejector-based ventilation device (DE 5) designed to provide an optimized entrainment effect for EVA. 16 The aims of this study were to compare the generated pressures, suction capacities, and entrainment ratios of the modified SBP 07 and the DE 5 and to determine the achievable minute volumes through a small-bore catheter in a simulated obstructed upper airway.
Methods
The modified SBP 07 (Figs 1A and 2A) has been described previously. 15 The modification of the original industrial device involved both removal of the silencer and connection of a modified T-piece as a flow control unit. The DE 5 consists of a specifically designed ejector with a 0.7 mm jet needle and an identical T-piece (Figs 1B and 2B). The driving gas, coming from a calibrated, pressure-compensated oxygen flowmeter, is highly accelerated by being forced through the jet needle and creates a negative pressure downstream of this needle. This effect is based on the Bernoulli principle and results in entrainment of gas through the side port (3 in Figs 1B and 2B ). By simply occluding the outlet ( jet/EVA switch; 2 in Figs 1B and 2B) of the ejector, the oxygen flow can be redirected to the transtracheal catheter (connected to 5 in Figs 1B and 2B).
To control the expiratory and inspiratory flows, a T-piece (part number 84048, Qosina, Edgewood, NY, USA) with an extra 4 mm side hole (on/off switch; 4 in Figs 1B and 2B) is attached to the side port of the ejector and functions as the flow control unit of the ventilation device.
In a pre-test bench study, it was shown that with the on/ off switch open, sufficient flow and pressure release is established and both the SBP 07 and the DE 5 thereby are functionally switched off, with no relevant flows and pressures acting downstream of the flow control unit. However, if the on/off switch is closed, the ejectors become active. By then alternately occluding and releasing the jet/EVA switch, either the oxygen flow is directed to the transtracheal catheter or a subatmospheric pressure is created to assist expiration ( Fig. 3A and B ).
Part 1: insufflation and suction pressures
In the first part of our study, the generated pressures of the modified SBP 07 and the DE 5 were studied. Both ejectors were connected to a calibrated, pressure- At oxygen flows of 6, 9, 12, 15, and 18 litre min 21 , the insufflation and suction pressures were measured at the distal T-piece, while simulating a static (no gas entrainment with the catheter tip closed) and a dynamic situation 
Part 3: inspiratory and expiratory times and minute volumes
In the third part of the study, the efficacy of the DE 5 at different pulmonary compliances and resistances was tested in an LS800 lung simulator (Drä ger Medical AG & Co. KG) with a simulated complete upper airway obstruction. The 75 mm long, 2 mm ID transtracheal catheter was tightly fitted in the proximal tube orifice of the lung simulator ensuring that the entire gas flow into and out of the bellows was guided through the catheter. To determine minute volumes, the times required for insufflation of 1000 ml of oxygen and the times needed for passive backflow of this volume through the catheter and for assisted expiration using the DE 5 were measured as previously described. 15 
Statistical analysis
For descriptive statistics, MS-Excel 2002 SP3 was used.
Results are presented as mean (SD). Suction capacities, entrainment ratios, and achievable minute volumes were calculated.
Results

Part 1: insufflation and suction pressures
The modified SBP 07 and the DE 5 generated similar insufflation pressures proportional to the flow rate of the driving gas (Table 1) . Subatmospheric pressures in both the static and the dynamic settings were proportional to the flow rate of the driving gas. In all static situations, except at a flow rate of 6 litre min 21 , the subatmospheric pressure generated by the DE 5 was less negative compared with that generated by the SBP 07 at the same flow rate. However, in all dynamic situations, the DE 5 maintained a more negative pressure.
Part 2: suction capacities and entrainment ratios
The suction capacity of the DE 5 was higher compared with that of the SBP 07 and ranged from 6.8 to 15.9 litre min 21 depending on the flow rate of the driving gas (Table 1) . Consequently, also the entrainment ratio of the DE 5 was higher than that of the SBP 07 at all flow rates. passive backflow of 1000 ml oxygen through the transtracheal catheter takes 9.9 (0.10) s. 15 Thus, at an oxygen flow of 15 litre min 21 repetitively connecting and disconnecting 17 Although this minute volume would be sufficient to re-establish oxygenation, hypercapnia seems to be inevitable. Optimizing expiratory ventilation assistance
To speed up expiration through a small-bore catheter, the driving force can be increased, for example, by applying compression to the thorax, abdomen, or both. The resistance of the outflow tract may also be diminished by inserting an additional transtracheal catheter to facilitate expiration. 6 18 19 To minimize trauma to the airway and to get more control over the expiration, it has also been suggested to augment the outflow of gas through a single small-bore catheter by the application of suction. 12 14 The mechanism of both tested devices (modified SBP 07 and DE 5) is based on the ejector's principle. An ejector is a multipurpose device able to create a subatmospheric pressure by the Bernoulli principle and to entrain air from a side port. The amount of entrainment and consequently the degree of expiratory assistance depend on the velocity of the driving gas and the resistance of the ejector. Although an ejector's resistance to flow is primarily defined by its inner geometry, the velocity of the driving gas jet passing through the ejector modulates the effective resistance while the ejector is active. If, at a given flow, the velocity of the driving gas is decreased (e.g. by turbulent mixing with entrained gas), an ejector will become less efficient.
The SBP 07 was modified and the DE 5 was specifically designed to serve as emergency ventilation ejectors, allowing both insufflation of oxygen and EVA. Although the modified SBP 07 has previously been reported to achieve a minute volume of more than 6 litre min 21 through a 75 mm long, 2 mm ID transtracheal catheter, 15 this industrial ejector has been designed to create a maximum negative pressure to pick up and hold parts during manufacturing processes in industrial assembly lines and is not specified for ventilation.
The results of this study show that the SBP 07 is indeed capable of generating a high negative pressure in a static situation, that is, no gas is entrained. However, in a dynamic situation, when gas is continuously entrained through the transtracheal catheter, the generated pressure was considerably less negative. Compared with the SBP 07, the DE 5 built up a less negative pressure in a static situation, but maintained a higher negative pressure in a dynamic situation, leading to an improved suction capacity and a higher entrainment ratio. The differences in test results prove that the design of the DE 5 turns it into being better suited for ventilation purposes than the SBP 07. As shown in Figure 2A and B, the outflow tract and the side port of the SBP 07 and the DE 5 are designed differently. The outflow tube of the SBP 07, having a constant diameter over three-quarters of its length, has an optimal shape for creating a maximum negative pressure build-up in a static situation. In contrast, the slightly conical shape of the outflow pipe of the DE 5 has a length and an internal diameter that were designed to maximize entrainment from the side port while minimizing inner turbulence and thus optimizing the egress of entrained gas.
We are aware of the fact that application of results from this in vitro study into clinical practice has its limitations. Completely blocking the upper airway is an extreme simplification of clinical reality. The diameter of the upper airway is dynamically variable, and in clinical practice, it will open up at a certain intratracheal (intrathoracic) pressure in most cases. Although this situation resembles a relatively rare event, we decided to simulate a completely blocked upper airway as the best experimental setting for the evaluation of the DE 5. Thus, the current study did not address the usefulness of the DE 5 in various degrees of upper airway obstruction and did not determine the influence of patency of the upper airway on the effect of EVA. Furthermore, the effects of EVA on gas exchange, lung tissue, and circulation have not yet been fully studied. Ongoing in vivo experiments will have to address these clinical questions.
In summary, our novel EVA applying ventilation ejector DE 5 is capable of achieving an adequate minute volume through a small-bore transtracheal catheter. If further research confirms the safety and applicability of EVA in vivo, the DE 5 might be used as a portable emergency ventilator for small-bore catheters in the future.
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